Dr Dina Tiniakos Professor Alastair Burt
| An End-to-End Platform for Digital Pathology Using Hyperspectral Autofluorescence Microscopy and Deep Learning-Based Virtual Histology | 2024 |
|
Professor Helen Reeves Dr Dina Tiniakos
| British Society of Gastroenterology guidelines for the management of hepatocellular carcinoma in adults | 2024 |
|
Matt McTeer Dr Dina Tiniakos Professor Cliff Brass Professor Quentin Anstee Professor Paolo Missier et al. | Machine learning approaches to enhance diagnosis and staging of patients with MASLD using routinely available clinical information | 2024 |
|
Dr Olivier Govaere Dr Megan Hasoon Dr Simon Cockell Dr Dina Tiniakos Professor Ann Daly et al. | A proteo-transcriptomic map of non-alcoholic fatty liver disease signatures | 2023 |
|
Kristy Wonders Dr Dina Tiniakos Professor Pierre Bedossa Professor Quentin Anstee
| Biomarkers for staging fibrosis and non-alcoholic steatohepatitis in non-alcoholic fatty liver disease (the LITMUS project): a comparative diagnostic accuracy study | 2023 |
|
Dr Jack Leslie Dr Jill Hunter Amy Collins Amelia Rushton Lauren Russell et al. | c-Rel–dependent Chk2 signaling regulates the DNA damage response limiting hepatocarcinogenesis | 2023 |
|
Kristy Wonders Dr Dina Tiniakos Professor Pierre Bedossa Professor Cliff Brass Professor Quentin Anstee et al. | Machine learning algorithm improves detection of NASH (NAS-based) and at-risk NASH: a development and validation study | 2023 |
|
Dr Brian Ford Dr Shruti Chachra Katrina Rodgers Tabassum Moonira Dr Ziad Al-Oanzi et al. | The GCKR-P446L gene variant predisposes to raised blood cholesterol and lower blood glucose in the P446L mouse-a model for GCKR rs1260326 | 2023 |
|
Dr Massimo Younes Dr Olivier Govaere Dr Dina Tiniakos Professor Alastair Burt Marco Zaki et al. | Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach? | 2022 |
|
Dr Suzanne Madgwick Dr Saimir Luli Helene Sellier Dr Jacqueline Butterworth Dr Jack Leslie et al. | Claspin haploinsufficiency leads to defects in fertility, hyperplasia and an increased oncogenic potential | 2022 |
|
Dr Steven Masson Dr Dina Tiniakos
| Clinical, histological and molecular profiling of different stages of alcohol-related liver disease | 2022 |
|
Dr Dina Tiniakos Professor Quentin Anstee
| Complexity of ballooned hepatocyte feature recognition: Defining a training atlas for artificial intelligence-based imaging in NAFLD | 2022 |
|
Dr Dina Tiniakos
| Consensus Recommendations for Histological Criteria of Autoimmune Hepatitis from the International AIH Pathology Group | 2022 |
|
Nicola Dyson Dr Nicole Kattner Minna Honkanen-Scott Bethany Hunter Jennifer Doyle et al. | Development and Application of a Semi quantitative Scoring Method for Ultrastructural Assessment of Acute Stress in Pancreatic Islets | 2022 |
|
Dr Dina Tiniakos
| Experimental Intestinal Stenosis Alters Crohn's Disease-Like Intestinal Inflammation in Ileitis-Prone Mice | 2022 |
|
Dr Dina Tiniakos
| How to identify, encourage, and support suitable candidates for leading roles in scientific societies: The UEG experience | 2022 |
|
Dr Katherine Johnson Dr Peter Leary Dr Olivier Govaere Dr Matthew Barter Sarah Charlton et al. | Increased serum miR-193a-5p during non-alcoholic fatty liver disease progression: Diagnostic and mechanistic relevance | 2022 |
|
Dr Olivier Govaere Dr Rebecca Darlay Dr Julien Peltier Dr Jeremy Palmer Dr Massimo Younes et al. | Macrophage Scavenger Receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease | 2022 |
|
Dr Dina Tiniakos
| Specific Neuropeptide Expression in Crohn's Disease Ileocolonic Resection Specimens Is Not Associated with Plexitis at the Ileal Margin or Postoperative Recurrence | 2022 |
|
Dr Marco Zaki Dr Sari Alhasan Dr Ruchi Shukla Misti McCain Maja Laszczewska et al. | Sulfatase-2 from Cancer Associated Fibroblasts: An Environmental Target for Hepatocellular Carcinoma? | 2022 |
|
Dr Dina Tiniakos
| “Dual aetiology fatty liver disease”: A recently proposed term associated with potential pitfalls | 2021 |
|
Dr Dina Tiniakos
| Adiponectin, Leptin, and IGF-1 Are Useful Diagnostic and Stratification Biomarkers of NAFLD | 2021 |
|
Dr Dina Tiniakos
| Burnout in gastroenterology: raise awareness and identify drivers | 2021 |
|
Dr Massimo Younes Rachel Burgoyne Dr Dina Tiniakos Dr Olivier Govaere
| Clinical implications of hepatic progenitor cell activation in non-alcoholic fatty liver disease | 2021 |
|
Dr Dina Tiniakos
| Development and prognostic relevance of a histologic grading and staging system for alcohol-related liver disease | 2021 |
|
Professor Alastair Burt Professor Pierre Bedossa Dr Dina Tiniakos
| Fifty years of impact on liver pathology: a history of the Gnomes | 2021 |
|
Dr Dina Tiniakos
| From the origin of NASH to the future of metabolic fatty liver disease | 2021 |
|
Dr Dina Tiniakos
| Inflammatory myoglandular polyp as a cause of recurrent abdominal pain in a patient with quiescent Crohn's disease | 2021 |
|
Dr Dina Tiniakos
| Keratin 7 expression in hepatic cholestatic diseases | 2021 |
|
Marco Zaki Dr Ahmed Mahdi Dr Gillian Patman Anna Whitehead Joao Mauricio et al. | Key features of the environment promoting liver cancer in the absence of cirrhosis | 2021 |
|
Dr Dina Tiniakos
| Liver stiffness measurements by 2-dimensional shear wave elastography compared to histological and ultrasound parameters in primary biliary cholangitis | 2021 |
|
Dr Massimo Younes Dr Olivier Govaere Dr Dina Tiniakos Professor Alastair Burt Marco Youssef William Zaki et al. | Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease | 2021 |
|
Dr Arianna Bianchi Dr Letizia Marchetti Dr Hannah Paish Dr Kile Green Dr Dina Tiniakos et al. | Moderate Exercise Inhibits Age-Related Inflammation, Liver Steatosis, Senescence, and Tumorigenesis | 2021 |
|
Dr Olivier Govaere Dr Dina Tiniakos Professor Pierre Bedossa Dr Simon Cockell Dr Massimo Younes et al. | NASH limits anti-tumor surveillance in immunotherapy-treated HCC | 2021 |
|
Dr Dina Tiniakos
| Tumor mutation burden testing: a survey of the International Quality Network for Pathology (IQN Path) | 2021 |
|
Dr Olivier Govaere Dr Dina Tiniakos Professor Quentin Anstee Professor Fiona Oakley
| Bone Morphogenic Protein 8B Promotes the Progression of Non-Alcoholic Steatohepatitis | 2020 |
|
Dr Dina Tiniakos
| Burnout among gastroenterologists: How to manage and prevent it | 2020 |
|
Dr Nicole Kattner Nicola Dyson Dr Yvonne Bury Dr Dina Tiniakos Tracey Davey et al. | Development and validation of a quantitative electron microscopy score to assess acute cellular stress in the human exocrine pancreas | 2020 |
|
Dr Dina Tiniakos
| Experimental Models of Partial Intestinal Obstruction in Young Mice: Establishment, and Evaluation | 2020 |
|
Professor Quentin Anstee Dr Rebecca Darlay Dr Simon Cockell Dr Olivier Govaere Dr Dina Tiniakos et al. | Genome-Wide Association Study of Non-Alcoholic Fatty Liver and Steatohepatitis in a Histologically-Characterised Cohort | 2020 |
|
Dr Dina Tiniakos
| Innervation of the proximal human biliary tree. | 2020 |
|
Dr Dina Tiniakos
| Metastatic Hepatic Epithelioid Hemangioendothelioma Treated with Olaratumab: A Falling Star Rising? | 2020 |
|
Dr Massimo Younes Dr Olivier Govaere Dr Dina Tiniakos Professor Alastair Burt Marco Zaki et al. | Presence of Serum Antinuclear Antibodies Does Not Impact Long-Term Outcomes in Nonalcoholic Fatty Liver Disease | 2020 |
|
Dr Massimo Younes Dr Olivier Govaere Dr Luca Miele Dr Dina Tiniakos Professor Alastair Burt et al. | Presence of Serum Antinuclear Antibodies Does Not Impact Long-Term Outcomes in Nonalcoholic Fatty Liver Disease | 2020 |
|
Dr Dina Tiniakos Susan Harrison Professor Quentin Anstee
| qFIBS: A Novel Automated Technique for Quantitative Evaluation of Fibrosis, Inflammation, Ballooning, and Steatosis in Patients with Non-Alcoholic Steatohepatitis | 2020 |
|
Dr Timothy Hardy Kristy Wonders Dr Massimo Younes Professor Pierre Bedossa Entesar Betelmal et al. | The European NAFLD Registry: a real-world longitudinal cohort study of nonalcoholic fatty liver disease | 2020 |
|
Dr Olivier Govaere Dr Simon Cockell Dr Dina Tiniakos Dr Rachel Queen Dr Massimo Younes et al. | Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis | 2020 |
|
Dr Dina Tiniakos
| Alcohol-Related Liver Disease: Areas of Consensus, Unmet Needs and Opportunities for Further Study | 2019 |
|
Dr Dina Tiniakos
| Bizarre stromal cells in Crohn's disease | 2019 |
|
Dr Dina Tiniakos
| Fibrosis and alcohol-related liver disease | 2019 |
|
Dr Marie Boyle Kate Hallsworth Dr Dina Tiniakos Professor Quentin Anstee
| Health-related Quality of Life in Non-alcoholic Fatty Liver Disease Associates With Hepatic Inflammation. | 2019 |
|
Dr Sam Tingle Dr Avinash Sewpaul Steven White Dr Dina Tiniakos
| Hepatocellular neoplasm of uncertain malignant potential associated with hepatic granulomas featuring p62-positive asteroid bodies. | 2019 |
|
Dr Maria Perugorria Professor Fiona Oakley Professor Jelena Mann Dr Dina Tiniakos Professor Derek Mann et al. | Non-parenchymal TREM-2 protects the liver from immune-mediated hepatocellular damage | 2019 |
|
Dr Joaquim Majo Dr Dina Tiniakos
| Pathology and natural history of organ fibrosis | 2019 |
|
Dr Marie Boyle Dr Dina Tiniakos Dr Olivier Govaere Dr Massimo Younes Professor Stuart McPherson et al. | Performance of the PRO-C3 collagen neo-epitope biomarker in non-alcoholic fatty liver disease | 2019 |
|
Dr Sameh Abou-Beih Dr Steven Masson Professor Fiona Oakley Dr Dina Tiniakos
| Sinusoidal and pericellular fibrosis in adult post-transplant liver biopsies: association with hepatic stellate cell activation and patient outcome | 2019 |
|
Dr Dina Tiniakos
| Successful treatment of noncirrhotic portal hypertension with eculizumab in paroxysmal nocturnal hemoglobinuria: A case report. | 2019 |
|
Dr Dave Houghton Dr Kate Hallsworth Dr Sophie Cassidy Christian Thoma Dr Leah Avery et al. | The degree of hepatic steatosis associates with impaired cardiac and autonomic function | 2019 |
|
Dr Dina Tiniakos Dr Diana Jurk
| A novel Sudan Black B-based analogue revives lipofuscin as a biomarker for in vivo senescence | 2018 |
|
Dr Dina Tiniakos
| Can reference images improve interobserver agreement in reporting liver fibrosis? | 2018 |
|
Dr Dina Tiniakos Professor Quentin Anstee Professor Alastair Burt
| Fatty Liver Disease | 2018 |
|
Dr Dina Tiniakos Joao Pais Maurício-Muir Professor Helen Reeves
| Fatty liver disease and hepatocellular carcinoma: The pathologist’s view | 2018 |
|
Sebastian Mafeld Jeremy French Dr Dina Tiniakos Dr Beate Haugk Professor Derek Manas et al. | Fibrolamellar Hepatocellular Carcinoma: Treatment with Yttrium-90 and Subsequent Surgical Resection | 2018 |
|
Dr Olivier Govaere Dr Dina Tiniakos
| Hepatic Progenitor Cells in Metastatic Liver Carcinomas | 2018 |
|
Dr Scott Anderson Dr Michael White Sarah Armour Rashmi Maheshwari Dr Dina Tiniakos et al. | Loss of end-differentiated β-cell phenotype following pancreatic islet transplantation | 2018 |
|
Dr Jess Dyson Dr Dina Tiniakos Professor David Jones
| The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines | 2018 |
|
Dr Dina Tiniakos
| A case of ruptured HCC in resolving NASH associated with type 2 diabetes: Is early detection of diabetes-related HCC feasible? | 2017 |
|
Professor Stuart McPherson Dr Nina Wilson Dr Dina Tiniakos Dr Jennifer Wilkinson Professor Alastair Burt et al. | A randomised controlled trial of losartan as an anti-fibrotic agent in non-alcoholic steatohepatitis | 2017 |
|
Professor Stuart McPherson Dr Timothy Hardy Dr Dina Tiniakos Professor Alastair Burt Professor Chris Day et al. | Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis | 2017 |
|
Dr Mikolaj Ogrodnik Dr Satomi Miwa Dr Dina Tiniakos Dr Caroline Wilson Professor Chris Day et al. | Cellular senescence drives age-dependent hepatic steatosis | 2017 |
|
Dr Dave Houghton Christian Thoma Dr Kate Hallsworth Dr Sophie Cassidy Dr Timothy Hardy et al. | Exercise Reduces Liver Lipids and Visceral Adiposity in Patients With Nonalcoholic Steatohepatitis in a Randomized Controlled Trial | 2017 |
|
Professor Alastair Burt Dr Dina Tiniakos
| Fibrosis evaluation by transient elastography in alcoholic liver disease: Is the histological scoring system impacting cutoff values? | 2017 |
|
Dr Timothy Hardy Dr Mujdat Zeybel Professor Chris Day Dr Christian Dipper Dr Steven Masson et al. | Plasma DNA methylation: A potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver disease | 2017 |
|
Dr Anna Moles Fernandez Dr Jacqueline Butterworth Dr Jill Hunter Dr Jack Leslie Helene Sellier et al. | A RelA(p65) Thr505 phospho-site mutation reveals an important mechanism regulating NF-kB dependent liver regeneration and cancer | 2016 |
|
Dr Dina Tiniakos
| Atrophic hepatocytes express keratin 7 in ischemia-associated liver lesions | 2016 |
|
Dr Dina Tiniakos Professor Quentin Anstee Professor Chris Day Professor Alastair Burt Dr John Brain et al. | Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference | 2016 |
|
Kile Green Dr Laura Jopson Dr Ben Barron-Millar Barbara Innes Sarah Pagan et al. | Early Molecular Stratification of High-risk Primary Biliary Cholangitis | 2016 |
|
Dr Sameh Abou-Beih Dr Steven Masson Professor Fiona Oakley Dr Dina Tiniakos
| Evaluation of centrilobular fibrosis in post-transplant liver: Preliminary results | 2016 |
|
Dr Dina Tiniakos
| Evaluation of liver fibrosis: “Something old, something new…” | 2016 |
|
Dr Jess Dyson Dr Dina Tiniakos Professor Stuart McPherson
| Liver toxicity associated with sofosbuvir, an NS5A inhibitor and ribavirin use | 2016 |
|
Dr Sari Alhasan Dr Beate Haugk Laura Ogle Dr Gary Beale Anna Long et al. | Sulfatase-2: a prognostic biomarker and candidate therapeutic target in patients with pancreatic ductal adenocarcinoma | 2016 |
|
Dr Dina Tiniakos
| Alcoholic and Non-alcoholic Fatty Liver Disease | 2015 |
|
Dr Dina Tiniakos
| Associations between dietary intake and the presence of the metabolic syndrome in patients with non-alcoholic fatty liver disease | 2015 |
|
Dr Dina Tiniakos
| Blood redox status is associated with the likelihood of nonalcoholic fatty liver disease irrespectively of diet's total antioxidant capacity | 2015 |
|
Professor Alastair Burt Dr Dina Tiniakos
| Diagnosis and Assessment of NAFLD: Definitions and Histopathological Classification | 2015 |
|
Anna Whitehead Dr Gillian Patman Professor Chris Day Dr Dina Tiniakos Professor Quentin Anstee et al. | Effects of FXR agonist PX20606 on tumour formation in animal models of non-alcoholic fatty liver disease | 2015 |
|
Dr Dina Tiniakos
| Estrogen receptors β1 and β2 are associated with distinct responses of estrogen receptor α-positive breast carcinoma to adjuvant endocrine therapy. | 2015 |
|
Dr Dina Tiniakos
| Histamine H3 and H4 Receptor Ligands Modify Vascular Histamine Levels in Normal and Arthritic Large Blood Vessels In Vivo | 2015 |
|
Dr Dina Tiniakos
| Increased abdominal fat levels measured by bioelectrical impedance are associated with histological lesions of nonalcoholic steatohepatitis. | 2015 |
|
Dr Dina Tiniakos
| Keratin 19 protein expression is an independent predictor of survival in human hepatocellular carcinoma | 2015 |
|
Dr Dina Tiniakos
| Liver innervation and hepatic function: new insights | 2015 |
|
Dr Caroline Wilson Dr Diana Jurk Nicola Fullard Paul Banks Dr Agata Page et al. | NFkB1 is a suppressor of neutrophil-driven hepatocellular carcinoma | 2015 |
|
Dr Dina Tiniakos Dr Yvonne Bury
| p62 (SQSTM1) expression in human liver disease: Preliminary results | 2015 |
|
Anna Whitehead Laura Ogle Dr Gillian Patman Dr Ali Anwar Dr Dina Tiniakos et al. | Ras and p-ERK in metabolic syndrome associated Hepatocellular Carcinoma (HCC) | 2015 |
|
Dr Dina Tiniakos Dr John Brain Dr Yvonne Bury
| Role of Histopathology in Autoimmune Hepatitis | 2015 |
|
Dr Anna Moles Fernandez Dr Jacqueline Butterworth Dr Jill Hunter Dr Dina Tiniakos Professor Derek Mann et al. | Thr505 RelA phosphorylation controls liver proliferative response and supresses NF-kappa B tumor-promoting activities | 2015 |
|
Dr Caroline Wilson Dr Lindsay Murphy Jack Leslie Dr Stuart Kendrick Jeremy French et al. | Ubiquitin C-terminal hydrolase 1: A novel functional marker for liver myofibroblasts and a therapeutic target in chronic liver disease | 2015 |
|
Professor Alastair Burt Dr Dina Tiniakos
| Well-differentiated hepatocellular neoplasm of uncertain malignant potential - reply | 2015 |
|
Dr Dina Tiniakos
| Adherence to the Mediterranean diet is associated with the severity of non-alcoholic fatty liver disease | 2014 |
|
Dr Dina Tiniakos
| CD138 (syndecan 1) expression in health and disease | 2014 |
|
Dr Dina Tiniakos
| Dental Pulp cells enhance bone healing in a rat osteotomy model | 2014 |
|
Dr Dina Tiniakos
| Estrogen receptor beta 2 is inversely correlated with Ki-67 in hyperplastic and noninvasive neoplastic breast lesions | 2014 |
|
Dr Dina Tiniakos
| Histological features of chronic hepatitis C in haemodialysis patients | 2014 |
|
Dr Dina Tiniakos
| Liver Function Breath Tests for Differentiation of Steatohepatitis from Simple Fatty Liver in Patients with Nonalcoholic Fatty Liver Disease | 2014 |
|
Dr Dina Tiniakos
| Liver regeneration: immunohistochemichal study of intrinsic hepatic innervation after partial hepatectomy in rats | 2014 |
|
Dr Dina Tiniakos
| Medial tibial stress syndrome: A skeleton from medieval Rhodes demonstrates the appearance of the bone surface | 2014 |
|
Dr Yvonne Bury Naomi Brown Dr Dina Tiniakos
| p53 expression in human hepatocellular carcinoma (HCC): correlation with dysadherin expression and patient prognosis | 2014 |
|
Dr Dina Tiniakos Professor Alastair Burt
| Pathology of the Liver Sinusoids | 2014 |
|
Dr Dina Tiniakos
| The impact of cereal grain consumption on the development and severity of non-alcoholic fatty liver disease | 2014 |
|
Dr Dina Tiniakos Professor Alastair Burt
| The liver, gallbladder and pancreas | 2014 |
|
Dr Yang-Lin Liu Professor Helen Reeves Professor Alastair Burt Dr Dina Tiniakos Professor Stuart McPherson et al. | TM6SF2 rs58542926 Influences Hepatic Fibrosis Progression in Patients with Non-Alcoholic Fatty Liver Disease | 2014 |
|
Professor Pierre Bedossa Professor Alastair Burt Dr Dina Tiniakos Dr John Brain Dr Yvonne Bury et al. | Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease | 2014 |
|
Dr Dina Tiniakos Dr John Brain Dr Yvonne Bury
| Utility and appropriateness of the FLIP algorithm and SAF score in the evaluation of biopsies of nonalcoholic fatty liver disease. | 2014 |
|
Professor Pierre Bedossa Professor Alastair Burt Dr Dina Tiniakos
| Well differentiated hepatocellular neoplasm of uncertain malignant potential: Proposal for a new diagnostic category | 2014 |
|
Dr Dina Tiniakos
| Application, Utility and Validation of a New Histological System for Classification of NAFLD in Patients with Metabolic Syndrome | 2013 |
|
Dr Dina Tiniakos
| E2F transcription factors and digestive system malignancies: How much do we know? | 2013 |
|
Dr Dina Tiniakos
| Estrogen receptor beta 2 is associated with poor prognosis in estrogen receptor alpha-negative breast carcinoma | 2013 |
|
Dr Dina Tiniakos
| Increased Density of Cutaneous Nerve Fibres in the Affected Dermatomes After Herpes Zoster Therapy | 2013 |
|
Dr Dina Tiniakos
| The Severity of Histologic Liver Lesions Is Independent of Body Mass Index in Patients With Nonalcoholic Fatty Liver Disease | 2013 |
|
Dr Dina Tiniakos
| E2F-1 is overexpressed and pro-apoptotic in human hepatocellular carcinoma | 2012 |
|
Dr Dina Tiniakos
| Significance of liver histology in HBsAg-positive, IgM anti-HBc-negative acute hepatitis B virus-related hepatitis | 2012 |
|
Dr Dina Tiniakos
| Treatment With Simvastatin Inhibits the Formation of Abdominal Aortic Aneurysms in Rabbits | 2012 |
|
Dr Dina Tiniakos
| Effect of Antiviral Therapy on the Immunohistochemical Expression of bcl-xL and Bax Protein in Patients With HBeAg-Negative Chronic Hepatitis B | 2011 |
|
Dr Dina Tiniakos
| Exercise for NAFLD: Does Intensity Matter? | 2011 |
|
Dr Dina Tiniakos
| Fighting the bushfire in HCC trials | 2011 |
|
Dr Dina Tiniakos
| Hepatitis B surface antigen: Relation to hepatitis B replication parameters in HBeAg-negative chronic hepatitis B | 2011 |
|
Dr Dina Tiniakos
| IGF-I ameliorates hippocampal neurodegeneration and protects against cognitive deficits in an animal model of temporal lobe epilepsy | 2011 |
|
Dr Dina Tiniakos
| Inflammation in nonalcoholic steatohepatitis | 2011 |
|
Dr Dina Tiniakos
| Insights into ectopic estrogen receptor expression, nucleocytoplasmic distribution and interaction with chromatin obtained with new antibodies to estrogen receptors α and β | 2011 |
|
Dr Dina Tiniakos
| Multiplexed analysis of angiogenesis and lymphangiogenesis factors predicts outcome for non-small cell lung cancer patients | 2011 |
|
Dr Dina Tiniakos
| Serum leptin and ghrelin in chronic hepatitis C patients with steatosis | 2011 |
|
Dr Dina Tiniakos
| Dysadherin expression in human hepatocellular carcinoma: preliminary results | 2010 |
|
Dr Dina Tiniakos
| Histopathology of nonalcoholic fatty liver disease | 2010 |
|
Dr Dina Tiniakos
| Primary Hepatic Actinomycosis | 2010 |
|
Dr Dina Tiniakos
| Thrombotic risk factors and liver histologic lesions in non-alcoholic fatty liver disease | 2009 |
|
Dr Dina Tiniakos
| KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for an European quality assurance program | 2008 |
|
Dr Dina Tiniakos Professor Alastair Burt
| Ontogeny of human intrahepatic innervation | 2008 |
|
Dr Dina Tiniakos
| Serum apoptotic caspase activity as a marker of severity in HBeAg-negative chronic hepatitis B virus infection | 2008 |
|
Dr Dina Tiniakos Dr John Anderson
| c-fos oncogene expression in human breast carcinoma | 2000 |
|
Dr Dina Tiniakos Dr John Anderson
| Production and characterization of monoclonal antibodies to the human c-fos oncoprotein effective an routinely-processed tissues | 2000 |
|
Dr Dina Tiniakos Dr John Anderson Dr Mary Robinson Professor David Neal
| c-jun oncogene expression in transitional cell carcinoma of the urinary bladder | 1994 |
|